Download as pdf or txt
Download as pdf or txt
You are on page 1of 7

CASE REPORT

CASE REPORTS OF IDIOPATHIC THROMBOCYTOPENIA


UNRESPONSIVE TO FIRST-LINE THERAPIES TREATED
WITH TRADITIONAL HERBAL MEDICINES BASED ON
SYNDROME DIFFERENTIATION
Juno Yang, KMD, PhD1,a Beom-Joon Lee, KMD, PhD2,a and
Jun-Hwan Lee, KMD, PhD3,4#

The objective of our study is to present two cases showing the splenectomy, and was then treated with a herbal medicine
effects of traditional Korean herbal medicines based on tradi- for 7 months, ultimately leading to sustained remission
tional Korean medicine (TKM) for the treatment of immune again. Many patients with resistance to first-line treatments
thrombocytopenic purpura (ITP). One patient showed no tend to be reluctant to undergo a splenectomy, considered a
response to treatment with steroids and an immunosuppres- standard second-line treatment. In conclusion, herbal med-
sive agent. Moreover, liver toxicity and side effects of steroids icines, based on TKM, may offer alternative treatments for
were evident. However, after he ceased conventional treatment persistent or chronic ITP that is resistant to existing first-line
and started to take an herbal medicine, his liver function treatments.
normalized and the steroid side effects resolved. Ultimately, he
achieved complete remission. Another patient with ITP had Keywords: idiopathic thrombocytopenic purpura, traditional
sustained remission after steroid therapy in childhood, but Korean medicine, syndrome differentiation, herbal medicine
extensive uterine bleeding and thrombocytopenia recurred
when she was 16 years old. She was managed with steroids (Explore 2017; 13:68-74 & 2017 The Authors. Published by
again for 2 years, but severe side effects occurred, and Elsevier Inc. This is an open access article under the CC BY-NC-
eventually she ceased taking steroids. She refused a ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).)

INTRODUCTION The primary first-line treatment of ITP is corticosteroids and


Primary idiopathic thrombocytopenic purpura (ITP) or pri- intravenous immunoglobulin (IVIG) or anti-D globulin (anti-
mary immune thrombocytopenia, is characterized by platelet D). Corticosteroids are usually the first choice, and IVIG or
destruction (to o100  109/L) in the absence of other causes anti-D is used as first-line treatment for patients for whom
or disorders that may be associated with thrombocytopenia. steroids are contraindicated. If first-line therapies fail, splenec-
The main clinical challenge of primary ITP lies in the tomy, rituximab, immunosuppressive agents (e.g., cyclophos-
increased risk of bleeding, although bleeding symptoms, phamide and azathioprine), and thrombopoietin-receptor
including epistaxis, petechiae, bruising, and purpura, are not agonists (e.g., romiplostim and eltrombopag) may be consid-
always present.1 ered as second-line treatments.2,3
Splenectomy has also been regarded as a standard second-
line treatment in the management of patients who are
1 Kyungheeyedang Oriental Medical Clinic, Suwon-City, Kyonggi-do, refractory to first-line treatments. Other second-line therapies
Republic of Korea are considered after the failure of splenectomy, but they are
2 Division of Allergy, Immune and Respiratory System, Department expensive and have various side effects.3 However, many
of Internal Medicine, College of Korean Medicine, Kyung Hee patients are reluctant to undergo a splenectomy because of
University, Seoul, Republic of Korea
the unpredictability of the response,4 its invasiveness,5 and
3 Clinical Research Division, Korea Institute of Oriental Medicine,
possible complications.6,7 Thus, many patients tend to post-
Daejeon, Republic of Korea
4 Korean Medicine Life Science, University of Science & Technology pone or avoid a splenectomy when possible.8
(UST), Campus of Korea Institute of Oriental Medicine, Daejeon, Between adults and children with ITP, there are several
Republic of Korea clinical differences. In the case of adult ITP treatment, the
a
Juno Yang and Beom-Joon Lee contributed equally as first spontaneous remission rate is lower, corticosteroids are used
author. more frequently, and splenectomy is more often considered.9
# Correspondence to: 1672 Yuseong-daero, Yuseong-gu, Daejeon, 34054, Syndrome differentiation is not only a typical traditional
Republic of Korea. Korean medical diagnostic system but also a key concept in
e-mail: omdjun@kiom.re.kr the practice of traditional Korean medicine (TKM). According

68 & 2017 The Authors. Published by Elsevier Inc. This is an open EXPLORE January/February 2017, Vol. 13, No. 1
access article under the CC BY-NC-ND license http://dx.doi.org/10.1016/j.explore.2016.10.007
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
ISSN 1550-8307/$36.00
to the syndrome differentiation diagnostic system, a disease
can be categorized into any of several different patterns based
on the analysis of clinical information obtained from the
following four major traditional diagnostic procedures: obser-
vation, listening, questioning, and pulse analyses. These
patterns are also used in traditional medical treatments,
including the prescription of herbal medicine and acupunc-
ture.10–12
There have been some reports demonstrating the efficacy of
herbal medicine instead of first-line treatments for ITP,13,14
and there was one report of treatment of childhood persistent
ITP with herbal medicine.15 However, there has been no
report demonstrating the effectiveness of herbal medicine in
treating adult persistent or chronic ITP patients who were
unresponsive to standard first-line therapies, based on the
syndrome differentiation diagnostic system.
Thus, in this article, we present two ITP patients, both of
whom were unresponsive to the first-line treatment or discon-
tinued conventional treatment due to the side effects of
steroids. Nonetheless, they achieved complete or partial
remission by taking herbal medicines based on syndrome
differentiation without requiring a splenectomy. Fig. 1. Timeline of interventions and outcomes in case 1. PDN,
prednisone; AZ, azathioprine; CS, cyclosporine; TKM, traditional
Korean medicine, red arrow: TKM clinic visit day.
CASE 1
A 25-year-old male patient, a Korean student who resided in platelet count of 49  109/L and aspartate aminotransferase
the Philippines, visited a local hospital with high fever (AST)/alanine transaminase (ALT) of 211/230 UI/L. The
(4401C) and a decreased platelet count (o100  109/L) in patient was taking oral prednisone 60 mg/d, calcium carbonate
January 2011, and was treated for dengue fever. The fever 40 mg/d, furocemide 40 mg/d, and celecoxib 400 mg/d.
became stable after 1 week, but the thrombocytopenia per- The patient was administered modified jigolpieum water
sisted. A bone marrow biopsy showed moderate megakaryo- extract orally (Table 1) three times per day under a diagnosis
cytic hyperplasia, and treatment with oral prednisone 60 mg/d of persistent ITP, and furocemide was stopped. After three
was started for newly diagnosed ITP on February 4. However, weeks, his platelet count increased to 126  109/L, and the
the patient was unresponsive to the treatment, and azathio- AST/ALT ratio decreased to 130/150 UI/L. The prednisone
prine 100 mg/d and prednisone 180 mg/d were administered was tapered down to 30 mg/d. However, the platelet count
orally on February 18. Subsequently, the patient started to then fell to 49  109/L because of the reduced steroid dose.
suffer from side effects of the steroid, including weight gain Thus, the herbal medicine was changed to a modified
and swelling, and liver toxicity was detected in a biochemical seongyutang with Salviae miltiorrhizae radix and Scutellariae
analysis on March 22. The azathioprine was replaced by radix water extract (Table 2). Subsequently, the platelet
cyclosporine 200 mg/d due to the liver toxicity. On April count increased again, and the AST/ALT ratio decreased
26, because of persistent liver toxicity, the immunosuppressive gradually. After three months, the steroid was discontinued.
drug—cyclosporine was stopped, and prednisone was reduced After four months, the platelet counts and AST/ALT ratio
to 60 mg/d. However, the platelet count still did not increase. were 232  109/L and 54/62 IU/L, respectively, the cutaneous
Moreover, the patient could not walk properly due to vertebral wound had healed, and the general condition of the patient
pain, weight gain, and peripheral edema in both legs. The had improved. Thus, the dose of the herbal medicine was
patient eventually came to Korea and visited our clinic in a tapered to two-thirds the previous dose. After five months, the
wheelchair on August 5 (Fig. 1). platelet counts and AST/ALT ratio were 184  109/L and 41/
On physical examination, the patient was unable to walk 47 IU/L, respectively, indicating a complete response; how-
due to severe back pain and peripheral edema and had a ever, the platelet count was maintained at 4100  109/L3.
cutaneous wound on his ankle that was not healing well. He Given the patient's recovery, the herbal medicine was discon-
was suffering from side effects of the steroid: moon face, tinued on January 7, 2012. Even with no medication, there
edema, weight gain, muscle weakness, and pain in the back was no bleeding sign, and the platelet count was still 4150 
and knees. An erythematous facial complexion and dark red- 109/L on May 15, 2014 (Fig. 2).
colored tiny petechiae were observed around his trunk and
neck. The patient also reported fatigue, mild irritability,
insomnia, thirst, and yellow urine. A taut, rapid, and weak CASE 2
pulse was found on pulse examination. A dark red and dry This 20-year-old female patient suffered from a common cold
tongue was observed. However, he had no bleeding symp- when she was eight years old. A local pediatric doctor
toms, and no splenomegaly. Laboratory analyses showed a administered a cutaneous intermuscular injection of

ITP Treated with Traditional Herbal Medicines EXPLORE January/February 2017, Vol. 13, No. 1 69
Table 1. Ingredients and Doses of the Modified jigolpieum Water Extract Used in Case 1 and Activities of the Herbs
Pharmaceutical Name Total Daily Dose (g/d) Main Activity of Herbal Drug in This Case
Lycii radicis cortex 15 Clear deficiency in heat
Moutan cortex 15 Activate blood and resolve stasis
Ginseng radix 12 Tonify Qi and engender fluid
Zingiberis rhizoma siccus 12 Tonify Qi and warm the interior
Cinnamomi cortex spissus 12 Tonify Qi and tonify Yang
Glycyrrhizae radix 6 Tonify Qi and harmonize Qi and blood
Angelicae gigantis radix 6 Nourish Yin and harmonize the blood
Cnidii rhizoma 6 Nourish Yin and activate blood; move Qi
Paeoniae radix rubra 6 Nourish Yin and activated blood; resolve stasis
Rehmanniae radix 6 Nourish Yin; enrich Yin; and subdue Yang
Poria (Hoelen) 12 Drain dampness and invigorate spleen and stomach
Alismatis rhizoma 12 Induce diuresis to alleviate edema

antibiotics in her hip, which produced an extensive hematoma On physical examination, the patient had no bleeding or
in the injected area. The patient was transferred to the petechiae. Her general condition was poor, and she felt
emergency room and treated with IVIG; however, treatment tired all the time. She was reported to have experienced
with steroids was maintained under a diagnosis of ITP. A bone lassitude, emaciation, low voice, dry mouth and throat,
marrow biopsy revealed erythroid hyperplasia and increased dizziness, mild insomnia, spontaneous sweating, intermit-
megakaryocytes. Despite the severe side effects of the steroids tent palpitations, and delayed menstruation cycles. A thin,
(stomach irritation, swelling, weight gain, and moon face), the weak, and rapid pulse was noted on pulse examination.
patient achieved a sustained remission approximately after six A pale tongue proper without coating was observed on
months. When the patient was 16 years old, she experienced tongue examination.
extensive uterine bleeding, and her platelet count decreased to She was treated with oral modified seongyutang with
8  109/L on January 10, 2010. She was treated with two Salviae miltiorrhizae radix, Artemisiae apiaceae herba, Lycii
cycles of IVIG, 1.0 g/kg/d intravenously for two days, and with radicis cortex, Biotae cacumen, and Lonicerae flos water extract
oral steroids 60 mg/d based on a diagnosis of relapsed severe (Table 3) three times per day. Although her platelet count
chronic ITP. She continued the oral steroid treatment for temporarily fell to 44  109/L due to hives, supposedly
approximately two years, and she showed a partial response caused by the summer heat, her platelet count increased
and sustained remission. However, the platelet count decreased gradually for seven months. On November 11, 2011, her
to 37  109/L on February 2, 2011. Furthermore, steroids side platelet count was maintained at 61  109/L and we stopped
effects such as bone pain, alopecia, weight gain, swelling, and the herbal medicine and continued to observe the patient.
fibromyalgia made the patient's symptoms much more serious. Since then, there has been no bleeding sign; her platelet
She finally stopped taking the steroids and visited our clinic count was 90  109/L on July 6, 2012, and 93  109/L on
seeking an alternative treatment on April 4, 2011 (Fig. 3). June 5, 2014 (Fig. 4).

Table 2. Ingredients and Doses of the Modified seongyutang Water Extract Used in Case 1 and Activities of the Herbs
Pharmaceutical Name Total Daily Dose (g/d) Main Activity of Herbal Drug in this Case
Astragali radix 30 Tonify Qi and secure the exterior
Ginseng radix 12 Tonify Qi and engender fluid
Zingiberis rhizoma siccus 12 Tonify Qi and warm the interior
Cinnamomi cortex spissus 12 Tonify Qi and tonify Yang
Glycyrrhizae radix 6 Tonify Qi; harmonize Qi and blood
Angelicae gigantis radix 6 Nourish Yin and harmonize the blood
Cnidii rhizoma 6 Nourish Yin, activate blood, and move Qi
Paeoniae radix rubra 6 Nourish Yin and activated blood; resolve stasis
Rehmanniae radix 6 Nourish Yin; enrich Yin; and subdue Yang
Atractylodis rhizoma 6 Resolve dampness to move Qi and fortify the spleen
Salviae miltiorrhizae radix 15 Tonify blood and activated blood to resolve stasis
Scutellariae radix 15 Purge fire, clear heat, and detoxify

70 EXPLORE January/February 2017, Vol. 13, No. 1 ITP Treated with Traditional Herbal Medicines
Fig. 2. Changes in platelet counts and AST/ALT ratio during the course of treatment in case 1. Plt, platelets; AST, aspartate aminotransferase;
ALT, alanine transaminase.

DISCUSSION children obtain complete responses with the first-line treat-


Primary ITP is an acquired autoimmune disorder characterized ment,  30% of children with newly diagnosed ITP progress
by a low platelet count in the peripheral blood without any to persistent or chronic ITP.18 In Korea, 22.5–37% of children
recognized cause, mediated by platelet antibodies that accel- with ITP develop persistent or chronic ITP,19 whereas  60%
erate platelet destruction, and inhibit their production.2,16 of adults with newly diagnosed ITP maintain a response after
Population-based studies have estimated the incidence of ITP initial treatment with standard first-line therapies, although
to be 1.9–6.4 per 100,000 children and 3.3 per 100,000 adults most adult patients exhibit chronic relapse after one year.20,21
per year.17 However, although two-thirds of newly diagnosed Second-line therapies, including splenectomy, rituximab,
immunosuppressive agents (e.g., cyclophosphamide and aza-
thioprine), and thrombopoietic-receptor agonists (e.g., romi-
plostim and eltrombopagand), are indicated for those patients
who are unresponsive to or relapse after initial first-line
therapies.3 For decades, splenectomy has been considered a
standard second-line therapy because it is highly effective and
inexpensive compared with other second-line therapies.2,22
Additionally, each of the other second-line therapies has
unique potential toxicities, such as immune suppression,
secondary malignancies, hypertension, and hepatic toxicity.
Thus, splenectomy has been recommended for patients who
fail corticosteroid therapy.3 Nevertheless, the number of
patients who opt to avoid a splenectomy has increased.5,23
Many patients are simply reluctant to remove a healthy organ
that has multiple hematological and immunological functions,
and to undergo an invasive and irreversible procedure. More-
over, the procedure itself can cause mortality and increases the
morbidity of various complications, including bacterial sep-
sis,7 vascular disease such as venous thromboembolism or
atherosclerosis,24 thrombosis,25 prolonged hospitalization,
readmission to the hospital, and the requirement of
additional interventions.6,8 In children, in particular, post-
splenectomy sepsis has risen to 3%, and an increased risk of
Fig. 3. Timeline of interventions and outcomes in case 2. PDN, sepsis probably persists for life.2
prednisone; IVIG, intravenous immunoglobulin, red arrow: TKM clinic In Korea, there are various norms for ITP treatment. Most
visit day. patients receive their initial diagnosis and management from a

ITP Treated with Traditional Herbal Medicines EXPLORE January/February 2017, Vol. 13, No. 1 71
Table 3. Ingredients and Doses in the Modified seongyutang Water Extract Used in Case 2 and Activities of the Herbs
Pharmaceutical Name Total Daily Dose (g/d) Main Activity of Herbal Drug in this Case
Astragali radix 30 Tonify Qi and secure the exterior
Ginseng radix 12 Tonify Qi and engender fluid
Zingiberis rhizoma siccus 12 Tonify Qi and warm the interior
Cinnamomi cortex spissus 12 Tonify Qi and tonify Yang
Glycyrrhizae radix 6 Tonify Qi; harmonize Qi and blood
Angelicae gigantis radix 6 Nourish Yin and harmonize the blood
Cnidii rhizoma 6 Nourish Yin, activate blood, and move Qi
Paeoniae radix rubra 6 Nourish Yin and activated blood; resolve stasis
Rehmanniae radix 6 Nourish Yin; enrich Yin; and subdue Yang
Salviae miltiorrhizae radix 15 Tonify blood and activated blood; resolve stasis
Artemisiae apiaceae herba 6 Clear heat to cool the blood
Lycii radicis cortex 15 Clear deficiency heat
Biotae cacumen 30 Dissipate blood stasis and resolve phlegm
Lonicerae flos 6 Clear heat to cool the blood and detoxify

hematologist and routinely undergo a bone marrow examina- carpenters or farmers.29 In this study, we defined remission as
tion. Regarding treatment, corticosteroids and anti-D are used Z26 consecutive weeks of a platelet count Z50  109/L after
commonly as first-line pharmacological treatments over IVIG, discontinuing the herbal medicine with no other ITP
and splenectomy is generally considered for ITP patients who treatment, 30 and complete remission was defined as a
show first-line treatment resistance.26,27 Nonetheless, because platelet count Z100  109/L.
of complications, many patients in Korea have also been Traditional herbal medicine has been used for thousands of
opting to defer a splenectomy as long as possible, and the need years in Korea. From the point of view of pathology, in
for alternative therapies before splenectomy to manage ITP traditional medicine based on syndrome differentiation, ITP is
unresponsive to first-line therapy has, therefore, increased. caused by blood heat expelling the blood from the vessels,
The main treatment goal in all ITP patients must be to which induces bleeding, such as epistaxis, plurimenorrhea,
maintain a safe platelet count, that is, not to normalize the ulemorrhagia, and petechiae. After bleeding, the extravasated
platelet count, but keep it at a level that will prevent or stop blood stagnates in the body (blood stasis) and inhibits
major bleeding. However, no treatment objective in persistent circulation, so as to aggravate the bleeding.31 In the chronic
or chronic ITP has been firmly defined as yet, and it is often stage, the retained blood heat and extravasated blood, which
driven by the desire to postpone or avoid the risks of more act like toxins, can exhaust Qi and Yin, resulting in their
extreme treatments such as a splenectomy or immunosuppres- deficiency.32 Thus, chronic ITP is treated primarily by
sion.28 Generally, most fatal bleeding has been reported to dissipating blood heat, removing toxins, promoting blood
occur in ITP patients whose platelet counts were o30  109/L. circulation, and by tonifYing Qi and nourishing Yin.33,34
Thus, a platelet count of 430  109/L is generally considered In Case 1, the patient was treated with prednisone as an
safe for patients who do not perform physical labor, such as initial therapy. Prednisone generally shows an initial response
within two weeks,2 but the patient was unresponsive to the
steroid. Thus, an immunosuppressant was added, and the
steroid dose was increased. However, the patient failed to
show any response over three months, and he experienced side
effects, including liver toxicity. The patient ceased the ongoing
conventional therapies and visited our clinic when the disease
had progressed to a chronic stage. We diagnosed him with
persistent ITP and a blood heat–predominant pattern, based
on Yin and Qi deficiency complex syndrome, according to the
traditional syndrome differentiation diagnosis system. Thus,
we administered a modified jigolpium water extract to initially
clear the toxins including the blood heat. He responded well,
and the steroid was tapered, but his platelet count then
decreased again. Next, we changed the herbal medicine to a
modified seongyutang water extract, invigorating the Qi and
Yin to promote blood circulation. After that, he showed a
Fig. 4. Changes in platelet counts during the course of treatment in continued complete response, and we discontinued the herbal
case 2. treatment. Three years later, he exhibited sustained complete

72 EXPLORE January/February 2017, Vol. 13, No. 1 ITP Treated with Traditional Herbal Medicines
remission, defined, as above, by a platelet count 4100  109/L 6. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for
without treatment. adult patients with idiopathic thrombocytopenic purpura: a
In Case 2, the patient experienced sustained remission after systematic review to assess long-term platelet count responses,
steroid therapy in childhood, but thrombocytopenia recurred prediction of response, and surgical complications. Blood.
2004;104(9):2623–2634.
with a low platelet level, 8  109/L, in January 2011. She
7. Boyle S, White RH, Brunson A, Wun T. Splenectomy and the
started to undergo ITP treatment again and continued to take incidence of venous thromboembolism and sepsis in patients with
oral steroids with a platelet count 430  109/L for two years. immune thrombocytopenia. Blood. 2013;121(23):4782–4790.
However, after two years of treatment, she had to discontinue 8. Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat
the steroid treatment because of side effects. She visited our immune thrombocytopenia: the choice between splenectomy or
clinic for an alternative therapy, and we diagnosed her with a a medical therapy as a second-line treatment. Blood. 2012;120(5):
blood-heat subordinate pattern based on Qi and Yin defi- 960–969.
ciency complex syndrome. Thus, we treated her with a 9. Schulze H, Gaedicke G. Immune thrombocytopenia in children
modified seongyutang water extract for seven months. She and adults: what's the same, what's different? Haematologica.
showed a continued partial response, defined as platelet count 2011;96(12):1739–1741.
10. Jiang M, Lu C, Zhang C, et al. Syndrome differentiation in
430  109/L.3 Given her busy schedule, the absence of
modern research of traditional Chinese medicine. J Ethnopharma-
bleeding allowed us to discontinue the herbal medicine and to col. 2012;140(3):634–642.
apply a “watchful observation” strategy.29 At about two years 11. Mei MF. A systematic analysis of the theory and practice of
later, her remission continued. syndrome differentiation. Chin J Integr Med. 2011;17(11):803–810.
In conclusion, herbal medicine based on TKM offers 12. Lu A, Jiang M, Zhang C, Chan K. An integrative approach
potential alternative therapies for patients with persistent or of linking traditional Chinese medicine pattern classification
chronic ITP who do not respond sufficiently to the first-line and biomedicine diagnosis. J Ethnopharmacol. 2012;141(2):
treatments: corticosteroids, IVIG, and anti-D. Still, very little 549–556.
is known about the biological mechanism of traditional herbal 13. Zhou Y, Hu M, Yang J, et al. Clinical study on idiopathic
medicines, and only limited data were generated in this study. thrombocytopenic purpura treated with Shengxueling Granule.
J Chin Integr Med. 2004;2(6):421–425.
Thus, further studies, including case–control studies and
14. Shao K-D, Zhou Y-H, Shen Y-P, Ye B-D, Gao R-I, Zhang Y.
randomized control trials with larger population sizes, are
Treatment of 37 patients with refractory idiopathic thrombocy-
needed to demonstrate the efficacy, safety, and biological topenic purpura by Shengxueling. J Chin Integr Med. 2007;13(1):
mechanism of herbal medicines in the treatment of ITP. 33–36.
15. Huang TP, Chang YH, Chen SH, Yang SL, Yen HR. Alternative
therapy for persistent childhood immune thrombocytopenic
CONFLICTS OF INTEREST purpura unresponsive to intravenous immunoglobulin. Comple-
The authors declare that they have no conflict of interest ment Ther Med. 2013;21(5):525–528.
regarding the publication of this article. 16. Lo E, Deane S. Diagnosis and classification of immune-mediated
The English in this document has been checked by at least thrombocytopenia. Autoimmun Rev. 2014;13(4):577–583.
two professional editors, both native speakers of English. For a 17. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN.
certificate, please see http://www.textcheck.com/certificate/ The incidence of immune thrombocytopenic purpura in children
pkLssI and adults: a critical review of published reports. Am J Hematol.
2010;85(3):174–180.
18. Kühne T, Imbach P, Bolton-Maggs PHB, Berchtold W, Blanch-
Acknowledgments ette V, Buchanan GR. Newly diagnosed idiopathic thrombocyto-
penic purpura in childhood: an observational study. Lancet.
2001;358(9299):2122–2125.
This research was supported by the Korea Institute of Oriental
19. Uk Hyun K, Sang In L, Kun Soo L. Early prediction of chronic
Medicine, South Korea (K16121) childhood immune thrombocytopenic purpura according to the
response of immunoglobulin treatment. Clin Pediatr Hematol
REFERENCES Oncol. 2013;20(2):79–85.
1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. 20. Rodeghiero F. First-line therapies for immune thrombocytopenic
N Engl J Med. 2002;346(13):995–1008. purpura: re-evaluating the need to treat. Eur J Haematol. 2008;80:
2. Provan D, Stasi R, Newland AC, et al. International consensus 19–26.
report on the investigation and management of primary immune 21. Cuker A, Prak ETL, Cines DB. Can Immune thrombocytopenia
thrombocytopenia. Blood. 2010;115(2):168–186. be cured with medical therapy? Semin Thromb Hemost. 2015;41
3. Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA. (04):395–404.
The American Society of Hematology 2011 evidence-based practice 22. Godeau B. Immune thrombocytopenic purpura: major progress in
guideline for immune thrombocytopenia. Blood. 2011;117(16): knowledge of the pathophysiology and the therapeutic strategy,
4190–4207. but still a lot of issues. Presse Méd (Paris, France: 1983). 2014;43
4. Balagué C, Vela S, Targarona E, et al. Predictive factors for (4 Pt 2):e47.
successful laparoscopic splenectomy in immune thrombocyto- 23. Marieke Schoonen W, Kucera G, Coalson J, et al. Epidemiology
penic purpura. Surg Endosc. 2006;20(8):1208–1213. of immune thrombocytopenic purpura in the General Practice
5. Janssens A, Lambert C, Bries G, Bosly A, Selleslag D, Beguin Y. Research Database. Br J Haematol. 2009;145(2):235–244.
Primary immune thrombocytopenia in adults. Belg J Hematol. 24. Crary SE, Buchanan GR. Vascular complications after splenec-
2013;4(1):2–11. tomy for hematologic disorders. Blood. 2009;114(14):2861–2868.

ITP Treated with Traditional Herbal Medicines EXPLORE January/February 2017, Vol. 13, No. 1 73
25. Fontana V, Jy W, Ahn E, et al. Increased procoagulant cell-derived treatment with the thrombopoietin mimetic romiplostim. Hema-
microparticles (C-MP) in splenectomized patients with ITP. tology 2015:1–6.
Thromb Res. 2008;122(5):599–603. 31. Chu Z-Z, Li N, Chen X-Y, Feng J-H, Huang Z-X, Xu L-M.
26. Kyung Soon S, Jung Lim L, Sun Joo C, et al. Long-term Examination of Chinese medicine treatment of idiopathic
observation of 87 cases with chronic idiopathic thrombocytopenic thrombocytopenic purpura. China J Tradit Chin Med Pharm.
purpura in adults. Korean J Hematol. 2000;35(3):233–240. 2012;5:038.
27. Heng L, Caguioa P, Chin N, et al. Chronic adult primary immune 32. Hoang B, Shaw D. Refractory idiopathic thrombocytopenic
thrombocytopenia (ITP) in the Asia–Pacific region. Int J Hematol. purpura: an integrated approach to treatment. J Orthomol Med.
2011;94(2):142–149. 2003;18(2):77–82.
28. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of 33. Chen Z, Dai W, Yu T, Yang H, Chen Y. Clinical observation
terminology, definitions and outcome criteria in immune throm- of therapy involving dispelling wind, cooling the blood, and
bocytopenic purpura of adults and children: report from an tonifYing the kidney for refractory idiopathic thrombocy-
international working group. Blood. 2008;113(11):2386–2393. topenic purpura. J Guangzhou Univ Tradit Chin Med. 2008;6:008.
29. Stasi R. Immune thrombocytopenic purpura: the treatment 34. Zhou Y-H, Wei K-M, He L-Y, et al. Multi-central clinical research
paradigm. Eur J Haematol. 2009;82:13–19. into treating 80 cases of chronic thrombocytopenia with Qi-
30. Bussel JB, Wang X, Lopez A, Eisen M. Case study of remission in supplementing and Yin-nourishing therapy and Western medi-
adults with immune thrombocytopenia following cessation of cine. J Tradit Chin Med. 2011;31(4):277–281.

74 EXPLORE January/February 2017, Vol. 13, No. 1 ITP Treated with Traditional Herbal Medicines

You might also like